4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-24-085092
EVP, Chief Development Officer acquired 3,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…